Dr. Reddy’s Laboratories rolls out Regadenoson Injection in US
Indian pharma company Dr. Reddy’s Laboratories said that it has launched Regadenoson Injection 0.4 mg/5 mL in the US market. Approved by the US Food and Drug Administration (FDA), Regadenoson Injection is a generic therapeutic equivalent of Lexiscan (Regadenoson) injection of Astellas US. It is a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI). […]